Buy IBM Stock On 'Short-Term Weakness,' Analyst Asserts After Q2 Performance - IBM ( NYSE:IBM )
Wedbush's Ives keeps $325 forecast on IBM, cites GenAI momentum and strong Q2 across software and infrastructure IBM's GenAI business hits $7.5B; Ives sees long-term growth and suggests buying the dip despite stock's drop Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On
https://www.benzinga.com/analyst-stock-ratings/reiteration/25/07/46613013/buy-ibm-stock-on-short-term-weakness-analyst-asserts-after-q2-performance